The Senate Health Education Labor and Pensions Committee suspended its markup on 2 May of four bipartisan bills designed to lower prescription drug prices amidst an unusually public disagreement between Chair Bernie Sanders, D-VT, and Republicans on the panel.
GOP members objected to what they described as primarily procedural issues stemming from Sanders diverging from an prior agreement with...